Metabolic dysfunction–associated steatotic liver disease (MASLD): Integrating metabolic and hepatic management into pharmacy practice

As treatment options for MASLD continue to emerge, it is crucial for pharmacists across all practice settings to optimize patient care. Optimization should occur through early recognition and management of comorbidities and disease, as well as by ensuring access to medications. Effective management of MASLD involves collaboration among all members of the healthcare team to enhance patient outcomes and maintain safety.